Komori
Monthly7476AS ONE CORPORATIONTrading & Wholesale

Notice of Unconsolidated Monthly Results (Preliminary) for August 2026

Standalone sales in August 2026 were ¥7,793 million, up 7.3% year on year. Sales increased in all 3 segments: Laboratory, Industry and Medical.

Worth reading
57In focus
Scored from 4 of 5 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
7.3
% (year on year)
Wording
Conditional
How definitive the wording is.

Sales for this month

August 2026fiscal year ending March 2027
7,793¥ million
Net Sales
-92.7%
The center line represents the same level as the same month of the previous year (100). The distance from the line represents the year-on-year change.
Year-on-year change by component
Laboratory
-95.6%
Medical
-91.8%
Industry
-88.8%
The bars use a logarithmic scale. This allows the relative sizes of the other items to be read even when one item is much larger than the others.
Monthly Commentary

August standalone sales rose 7.3% year on year, with all 3 segments posting higher sales. Laboratory growth was limited by the base effect of a large order in the same month last year, while Industry and Medical also recorded higher sales.

Factors Affecting the Change

Base effect of a large Laboratory order in the same month last year, Strong orders for research equipment, Strong orders from the semiconductor sector benefiting from expanding AI demand, Government support measures for medical institutions, Orders for disaster preparedness supplies

Monthly trend for the same period last year

Month April / Net Sales ¥8,228 million, Month May / Net Sales ¥7,792 million, Month June / Net Sales ¥8,524 million, Month July / Net Sales ¥8,911 million, Month August / Net Sales ¥7,262 million, Month September / Net Sales ¥8,423 million, Month October / Net Sales ¥9,140 million, Month November / Net Sales ¥7,880 million, Month December / Net Sales ¥9,513 million, Month January / Net Sales ¥9,314 million, Month February / Net Sales ¥9,290 million, Month March / Net Sales ¥11,327 million

Scope of aggregation: Standalone

Sales for this month
ItemDetails
Month CoveredAugust 2026
Fiscal Year Coveredfiscal year ending March 2027
Scope of aggregationStandalone
Net sales for the month¥7,793 million
Year-on-year change in monthly net sales7.3
Year-on-year change by categoryName Laboratory / Year on year 4.4, Name Industry / Year on year 11.2, Name Medical / Year on year 8.2
Sales by categoryLaboratory ¥4,406 million, Industry ¥1,850 million, Medical ¥1,284 million
Key KPIsSales per business day 7.3 % (year on year)
Monthly CommentaryAugust standalone sales rose 7.3% year on year, with all 3 segments posting higher sales. Laboratory growth was limited by the base effect of a large order in the same month last year, while Industry and Medical also recorded higher sales.
Factors Affecting the ChangeBase effect of a large Laboratory order in the same month last year, Strong orders for research equipment, Strong orders from the semiconductor sector benefiting from expanding AI demand, Government support measures for medical institutions, Orders for disaster preparedness supplies
Monthly trend for the same period last yearMonth April / Net Sales ¥8,228 million, Month May / Net Sales ¥7,792 million, Month June / Net Sales ¥8,524 million, Month July / Net Sales ¥8,911 million, Month August / Net Sales ¥7,262 million, Month September / Net Sales ¥8,423 million, Month October / Net Sales ¥9,140 million, Month November / Net Sales ¥7,880 million, Month December / Net Sales ¥9,513 million, Month January / Net Sales ¥9,314 million, Month February / Net Sales ¥9,290 million, Month March / Net Sales ¥11,327 million
Items this document does not state (11)
Total-store sales, year on yearSame-Store Sales, Year on YearYear-on-Year Change in Customer CountYear-on-Year Change in Average Spend per CustomerCumulative Sales from Start of PeriodCumulative Year-on-Year Change from Start of PeriodNumber of Stores at Period-EndNumber of stores opened during the monthNumber of stores closed during the monthMeasures from the following month onwardNext Scheduled Disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Laboratory orders were strong, particularly for research equipment, but growth was limited to 4.4% due to the base effect of a large order in the same month last year. Industry benefited from strong orders from the semiconductor sector, which is benefiting from expanding AI demand, while Medical was supported by government support measures for medical institutions and orders for disaster preparedness supplies.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Unconsolidated Monthly Results (Preliminary) for August 2026 | AS ONE CORPORATION (7476) timely disclosure | Komori